Literature DB >> 29075971

Minimally invasive surgery as a treatment option for gastric cancer with liver metastasis: a comparison with open surgery.

Jiyang Li1, Hongqing Xi1, Jianxin Cui1, Kecheng Zhang1, Yunhe Gao1, Wenquan Liang1, Aizhen Cai1, Bo Wei2, Lin Chen3.   

Abstract

BACKGROUND: As minimally invasive techniques advances, minimally invasive surgery (MIS) has emerged as an alternative modality for advanced gastric cancer. In this study, we compared the short- and long-term surgical outcomes of MIS and conventional open surgery for gastric cancer liver metastasis (GCLM) in terms of safety, feasibility, and efficacy.
METHODS: This retrospective study used data from a prospective database at the Chinese People's Liberation Army General Hospital. From January 2006 to June 2016, 53 gastric cancer patients with synchronous liver metastasis accepted radical gastrectomy combined with either or both hepatectomy and radiofrequency ablation for liver metastases. The 53 patients enrolled in the study were divided into two groups: a conventional open surgery group (n = 42) and an MIS group (n = 11). Propensity score matching (PSM) analysis was performed to overcome possible bias.
RESULTS: With PSM performed at a 1:3 ratio, 11 patients who received MIS were compared with 33 open surgery cases. Mean operation time was significantly longer for the MIS group compared with the open surgery group (301 vs. 236 min, P = 0.032), while the open surgery group had a larger estimated blood loss than the MIS group (421 vs. 196 ml, P = 0.019). Time to first flatus and postoperative complications, including Clavien-Dindo classification, were similar in the two groups. However, patients undergoing MIS had a significantly shorter time to first sips of water (P = 0.020) and soft diet (P = 0.020) compared with open surgery counterparts. Long-term outcomes were comparable between groups (P = 0.090) after adjustment by PSM analysis.
CONCLUSIONS: MIS achieved superior short-term outcomes and comparable long-term outcomes compared with open surgery in GCLM patients. For experienced surgeons, both laparoscopic and robotic methods of MIS are reasonable approaches for the management of highly selected GCLM patients.

Entities:  

Keywords:  Gastric cancer; Liver metastasis; Minimally invasive surgery; Robotics

Mesh:

Year:  2017        PMID: 29075971     DOI: 10.1007/s00464-017-5826-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  40 in total

Review 1.  Robotic surgery: a current perspective.

Authors:  Anthony R Lanfranco; Andres E Castellanos; Jaydev P Desai; William C Meyers
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

2.  Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures.

Authors:  Jyewon Song; Sung Jin Oh; Wook Ho Kang; Woo Jin Hyung; Seung Ho Choi; Sung Hoon Noh
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

3.  Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.

Authors:  Yanfeng Hu; Changming Huang; Yihong Sun; Xiangqian Su; Hui Cao; Jiankun Hu; Yingwei Xue; Jian Suo; Kaixiong Tao; Xianli He; Hongbo Wei; Mingang Ying; Weiguo Hu; Xiaohui Du; Pingyan Chen; Hao Liu; Chaohui Zheng; Fenglin Liu; Jiang Yu; Ziyu Li; Gang Zhao; Xinzu Chen; Kuan Wang; Ping Li; Jiadi Xing; Guoxin Li
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

4.  Predictive factors improving survival after gastric and hepatic surgical treatment in gastric cancer patients with synchronous liver metastases.

Authors:  Jing Liu; Jing-Hui Li; Ru-Jun Zhai; Bo Wei; Ming-Zhe Shao; Lin Chen
Journal:  Chin Med J (Engl)       Date:  2012-01       Impact factor: 2.628

5.  Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer.

Authors:  H Hayashi; T Ochiai; H Shimada; Y Gunji
Journal:  Surg Endosc       Date:  2005-07-28       Impact factor: 4.584

6.  Benefits and limits of hepatic resection for gastric metastases.

Authors:  S Ambiru; M Miyazaki; H Ito; K Nakagawa; H Shimizu; H Yoshidome; Y Shimizu; N Nakajima
Journal:  Am J Surg       Date:  2001-03       Impact factor: 2.565

7.  Robotic Versus Open Hepatectomy for Hepatocellular Carcinoma: A Matched Comparison.

Authors:  Po-Da Chen; Chao-Ying Wu; Rey-Heng Hu; Wei-Han Chou; Hong-Shiee Lai; Jin-Tung Liang; Po-Huang Lee; Yao-Ming Wu
Journal:  Ann Surg Oncol       Date:  2016-10-24       Impact factor: 5.344

8.  Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study.

Authors:  Hyung-Ho Kim; Sang-Uk Han; Min-Chan Kim; Woo Jin Hyung; Wook Kim; Hyuk-Joon Lee; Seung Wan Ryu; Gyu Seok Cho; Kyo Young Song; Seong Yeob Ryu
Journal:  J Clin Oncol       Date:  2014-01-27       Impact factor: 44.544

Review 9.  World review of laparoscopic liver resection-2,804 patients.

Authors:  Kevin Tri Nguyen; T Clark Gamblin; David A Geller
Journal:  Ann Surg       Date:  2009-11       Impact factor: 12.969

10.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.

Authors:  Peter C Austin
Journal:  Pharm Stat       Date:  2011 Mar-Apr       Impact factor: 1.894

View more
  7 in total

1.  Comparison of robotic- and laparoscopic-assisted gastrectomy in advanced gastric cancer: updated short- and long-term results.

Authors:  Yunhe Gao; Hongqing Xi; Zhi Qiao; Jiyang Li; Kecheng Zhang; Tianyu Xie; Weisong Shen; Jianxin Cui; Bo Wei; Lin Chen
Journal:  Surg Endosc       Date:  2018-07-16       Impact factor: 4.584

2.  Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER-based study.

Authors:  Miao-Zhen Qiu; Si-Mei Shi; Zhan-Hong Chen; Hong-En Yu; Hui Sheng; Ying Jin; De-Shen Wang; Feng-Hua Wang; Yu-Hong Li; Dan Xie; Zhi-Wei Zhou; Da-Jun Yang; Rui-Hua Xu
Journal:  Cancer Med       Date:  2018-07-09       Impact factor: 4.452

3.  Radiofrequency ablation versus traditional liver resection and chemotherapy for liver metastases from gastric cancer.

Authors:  Kezhong Tang; Bo Zhang; Linping Dong; Lantian Wang; Zhe Tang
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

4.  Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases.

Authors:  Kecheng Zhang; Lin Chen
Journal:  Ther Adv Med Oncol       Date:  2020-02-20       Impact factor: 8.168

5.  HIFU for the treatment of gastric cancer with liver metastases with unsuitable indications for hepatectomy and radiofrequency ablation: a prospective and propensity score-matched study.

Authors:  Bin Zhou; Ning He; Jiaze Hong; Tong Yang; Derry Minyao Ng; Xudong Gao; Kun Yan; Xiaoxiang Fan; Zhi Zheng; Ping Chen; Jianjun Zheng; Qi Zheng
Journal:  BMC Surg       Date:  2021-07-12       Impact factor: 2.102

Review 6.  Efficacy of Surgery for the Treatment of Gastric Cancer Liver Metastases: A Systematic Review of the Literature and Meta-Analysis of Prognostic Factors.

Authors:  Gianpaolo Marte; Andrea Tufo; Francesca Steccanella; Ester Marra; Piera Federico; Angelica Petrillo; Pietro Maida
Journal:  J Clin Med       Date:  2021-03-09       Impact factor: 4.241

7.  Clinicopathological features and prognostic analysis of signet ring cell gastric carcinoma: a population-based study.

Authors:  Shuai Guo; Mu-Yan Shang; Zhe Dong; Jun Zhang; Yue Wang; Zhi-Chao Zheng; Yan Zhao
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.